Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection

Background. Hepatitis C is a leading cause of mortality among HIV-infected individuals. Therefore, eradication of HCV in this population is a priority. There are scarce data regarding retreatment efficacy of HIV/ HCV coinfected patients. The aim of our study was to evaluate efficacy, predictors of r...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Mario Peribañez-Gonzalez, Mariliza Henrique daSilva, Fernando Crivelenti Vilar, Ana Catharina Seixas-Santos Nastri, Paulo Abrão Ferreira, Roberto Focaccia, Maria Cássia Mendes Correa
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2013-03-01
Saila:	Annals of Hepatology
Gaiak:	Non-responders HIV-HCV coinfected AIDS Efficacy Treatment
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S1665268119313614
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!